NASDAQ:AQST - Aquestive Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$6.58 -0.08 (-1.20 %)
(As of 02/20/2019 05:07 AM ET)
Previous Close$6.66
Today's Range$6.40 - $7.07
52-Week Range$5.60 - $20.70
Volume70,200 shs
Average Volume98,411 shs
Market Capitalization$164.11 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Analyst Ratings

Aquestive Therapeutics (NASDAQ:AQST) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Aquestive Therapeutics in the last 12 months. Their average twelve-month price target is $24.25, suggesting that the stock has a possible upside of 268.54%. The high price target for AQST is $30.00 and the low price target for AQST is $14.00. There are currently 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $24.25$24.25$29.00$26.00
Price Target Upside: 268.54% upside237.74% upside63.38% upside62.50% upside

Aquestive Therapeutics (NASDAQ:AQST) Consensus Price Target History

Price Target History for Aquestive Therapeutics (NASDAQ:AQST)

Aquestive Therapeutics (NASDAQ:AQST) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/3/2019Lake Street CapitalInitiated CoverageBuy ➝ Buy$14.00LowView Rating Details
12/20/2018WedbushSet Price TargetBuy AQST$30.00HighView Rating Details
11/7/2018Royal Bank of CanadaSet Price TargetBuy$24.00LowView Rating Details
8/20/2018JMP SecuritiesInitiated CoverageOutperform$29.00LowView Rating Details
8/20/2018BMO Capital MarketsInitiated CoverageOutperformLowView Rating Details
(Data available from 2/20/2017 forward)
This page was last updated on 2/20/2019 by MarketBeat.com Staff

Featured Article: Cost of Equity

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel